Literature DB >> 173268

Neostigmine methylsulfate. Does it have a chronic effect as well as a transient one?

M D Ward, M S Forbes, T R Johns.   

Abstract

Three groups of 200-gm rats were injected subcutaneously with neostigmine methylsulfate (1 mg/kg/day) for 7, 30, and 100 days. Electrophysiological changes were assessed in vitro, using microelectrode techniques to examine diaphragm muscles of treated and untreated animals. Miniature end-plate potential (MEPP) amplitude decreased in neostigmine-treated preparations. Guanidine hydrochloride enhances transmitter release and increases MEPP frequency in control preparations. Neostigmine-treated animals examined between 6 to 72 hours after discontinuation of neostigmine therapy showed impaired response to the facilitating influence of guanidine. Recovery of response to guanidine was inversely related to length of treatment with neostigmine. Results of electron-microscopic examination of motor end-plates in treated animals revealed ultrastructural changes, including simplified end-plates, and, occasionally, multiple, separate, junctional regions. Therefore, the chronic administration of cholinesterase inhibitors in man may have a deleterious effect, as well as a transient beneficial one.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173268     DOI: 10.1001/archneur.1975.00490540052006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction.

Authors:  M Gwilt; D Wray
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

2.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

3.  Influence of neostigmine treatment on embryonic development of acetylcholine receptors and neuromuscular junctions.

Authors:  G S Sohal; W R Boydston
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

4.  β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.

Authors:  An E Vanhaesebrouck; Richard Webster; Susan Maxwell; Pedro M Rodriguez Cruz; Judith Cossins; James Wickens; Wei-Wei Liu; Hakan Cetin; Jonathan Cheung; Hayley Ramjattan; Jacqueline Palace; David Beeson
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

5.  Efficacy and Safety of Neostigmine Adjunctive Therapy in Patients With Sepsis or Septic Shock: A Randomized Controlled Trial.

Authors:  Mona M El-Tamalawy; Moetaza M Soliman; Amany F Omara; Amal Rashad; Osama M Ibrahim; Mamdouh M El-Shishtawy
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.